The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism
- PMID: 1501114
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism
Abstract
The angiotensin II (AII) receptor antagonist, DuP 753 (10 mg/kg intraduodenal), produced a sustained and long-lasting antihypertensive effect in conscious renin-dependent hypertensive rats. Blood pressures were still reduced markedly 24 to 72 hr after administration of a single dose of DuP 753. However, pressor responses elicited by either angiotensin I or AII were not blocked at these times despite the continued antihypertensive effect of DuP 753. In a model of orthostatic hypotension, DuP 753 and the selective alpha-1 adrenoceptor antagonist prazosin produced a marked orthostatic hypotension response in renin-dependent hypertensive rats as demonstrated by potentiation of the decrease in blood pressure induced by a 90 degrees tilt. The nonpeptide AII receptor antagonist SK&F 108566 (10 mg/kg intraduodenal) did not produce orthostatic hypotension and the angiotensin converting enzyme inhibitor enalapril produced only a slight orthostatic response to tilting. In conscious spontaneously hypertensive rats (SHR), allowed 3 to 4 days to recover from surgery, administration of either enalapril (1 mg/kg i.v.) or SK&F 108566 (10 mg/kg i.v.) did not significantly effect blood pressure. In SHR tested within 24 hr of surgery, enalapril was effective in lowering blood pressure. In contrast, in surgically recovered SHR, DuP 753 (10 mg/kg i.v.) produced an antihypertensive effect that was slow in onset, sustained and extremely long in duration. Blood pressures did not return to predrug levels until 48 hr after administration of DuP 753. Stimulation of the thoracolumbar sympathetic outflow in pithed rats produced frequency-dependent pressor responses that were significantly potentiated by continuous infusion of a subpressor dose of AII.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.J Pharmacol Exp Ther. 1990 Feb;252(2):726-32. J Pharmacol Exp Ther. 1990. PMID: 2179532
-
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.J Pharmacol Exp Ther. 1990 Feb;252(2):719-25. J Pharmacol Exp Ther. 1990. PMID: 2179531
-
Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.J Pharmacol Exp Ther. 1991 Nov;259(2):861-70. J Pharmacol Exp Ther. 1991. PMID: 1941632
-
Angiotensin II receptor antagonists. From discovery to antihypertensive drugs.Hypertension. 1991 Nov;18(5 Suppl):III136-42. doi: 10.1161/01.hyp.18.5_suppl.iii136. Hypertension. 1991. PMID: 1937677 Review.
-
In vivo pharmacology of DuP 753.Am J Hypertens. 1991 Apr;4(4 Pt 2):288S-298S. doi: 10.1093/ajh/4.4.288s. Am J Hypertens. 1991. PMID: 1854454 Review.
Cited by
-
Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats.Br J Pharmacol. 2005 Mar;144(6):755-60. doi: 10.1038/sj.bjp.0706039. Br J Pharmacol. 2005. PMID: 15685215 Free PMC article.
-
In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.Br J Pharmacol. 1995 Jan;114(2):405-13. doi: 10.1111/j.1476-5381.1995.tb13241.x. Br J Pharmacol. 1995. PMID: 7881741 Free PMC article.
-
Angiotensin II during Experimentally Simulated Central Hypovolemia.Front Cardiovasc Med. 2016 Mar 3;3:6. doi: 10.3389/fcvm.2016.00006. eCollection 2016. Front Cardiovasc Med. 2016. PMID: 26973842 Free PMC article. Review.
-
Control of cardiomyocyte gene expression as drug target.Mol Cell Biochem. 2000 Sep;212(1-2):135-42. Mol Cell Biochem. 2000. PMID: 11108145 Review.
-
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.Br J Pharmacol. 1994 Jan;111(1):137-44. doi: 10.1111/j.1476-5381.1994.tb14035.x. Br J Pharmacol. 1994. PMID: 8012689 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical